Untargeted lipidomics of liver to assess the potential protective role in atherosclerosis progression of A12 antibodies infusion into LDLR-/-mice

Accession: ST001434
Source / host: Metabolomics Workbench — NIH Metabolomics Workbench
Disease relevance: MASLD / NAFLD / NASH (category: Metabolomic, subtype: metabolomics/lipidomics)
Modality / assay: metabolomics
Platform:
Organism: unspec
Size (indexed): 24.2 KB (24770 bytes)
Downloaded bytes: 24.2 KB (24770 bytes)
Access / raw: public / OPEN-processed

Download

Files

FileSizeSHA256
ST001434_mwtab.txt19.5 KB062ea7f032981f96…
ST001434_factors.json4.1 KB0393bfe57195cd51…
ST001434_summary.json659 Bae8723cd76aff147…

Index note: processed mwTab+data+factors; 3 files 24.2 KB

Crawled by masld-atlas-crawler v1.0 at 2026-08-06T04:28:10Z.

About this dataset

This 10x Genomics dataset provides single-cell gene expression from unspec liver samples, with disease state recorded as MASLD/NAFLD/NASH. Beyond gene expression it includes a targeted gene panel.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.